Jan Hendrik Moltz

5PUBLICATIONS
11CO-AUTHORS
Radiation therapyDecision makingPredictive and prognostic markersDeep learning
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 11, 2025
Correction: Peisen et al. Can Delta Radiomics Improve the Prediction of Best Overall Response, Progression-Free Survival, and Overall Survival of Melanoma Patients Treated with Immune Checkpoint Inhibitors? Cancers 2024, 16, 2669.

Felix Peisen, Annika Gerken, Alessa Hering

|Dec 17, 2024
Reliability of Automated RECIST 1.1 and Volumetric RECIST Target Lesion Response Evaluation in Follow-Up CT-A Multi-Center, Multi-Observer Reading Study.

Isabel C Dahm, Manuel Kolb, Sebastian Altmann

|Aug 10, 2024
Can Delta Radiomics Improve the Prediction of Best Overall Response, Progression-Free Survival, and Overall Survival of Melanoma Patients Treated with Immune Checkpoint Inhibitors?

Felix Peisen, Annika Gerken, Alessa Hering

|Nov 27, 2021
Quantitative Imaging Biomarkers of the Whole Liver Tumor Burden Improve Survival Prediction in Metastatic Pancreatic Cancer.

Leonie Gebauer, Jan H Moltz, Alexander Mühlberg

|Nov 16, 2020
Hippocampus segmentation in CT using deep learning: impact of MR versus CT-based training contours.

Annika Hänsch, Jan Hendrik Moltz, Benjamin Geisler

Pageof 1

Frequent Collaborators

3 joint publications

Konstantin Nikolaou

2 joint publications

Felix Peisen

2 joint publications

Thomas K Eigentler

2 joint publications

Teresa Amaral